Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial

Published:2017-05 Issue: Volume:251 Page:182-191
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Jahangard Leila,Akbarian Shahrokh,Haghighi Mohammad,Ahmadpanah Mohammad,Keshavarzi Amir,Bajoghli Hafez,Sadeghi Bahmani Dena,Holsboer-Trachsler Edith,Brand Serge

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference47 articles.

1. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ;Aman;J. Child Adolesc. Psychopharmacol.,2004

2. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?;Aman;J. Am. Acad. Child Adolesc. Psychiatry,2014

3. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children;Aman;Res. Dev. Disabil.,2009

4. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Washington, DC

5. Risperidone versus methylphenidate in treatment of preschool children with attention-deficit hyperactivity disorder;Arabgol;Iran. J. Pediatr.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder;Expert Review of Neurotherapeutics;2024-06-25

2. Contemporary diagnosis and treatment of conduct disorder in youth;Expert Review of Neurotherapeutics;2023-10-19

3. Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review;Biomedicines;2022-11-04

4. A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents;Journal of Child and Adolescent Psychopharmacology;2022-09-01

5. The Use of Brexpiprazole Combined With a Stimulant in Adults With Treatment-Resistant Attention-Deficit/Hyperactivity Disorder;Journal of Clinical Psychopharmacology;2022-08-18